MediSieve

Operator of a biotechnology company intended to develop magnetic blood filtration devices for treating blood-borne diseases. The company offers a magnetic haemofiltration platform that enables the physical removal of specific substances from the bloodstream of patients and can be used as a direct treatment, or to increase the safety and efficacy of other therapies or physically remove specific substances from the bloodstream of patients, enabling hospitals and healthcare firms to tackle diseases such as sepsis, malaria, Covid-19 and remove human plasma.

Partnerships

 

  

  

 

  

  

 

  

  

Clients